Flemming Bendtsen

Flemming Bendtsen

Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


  1. 2021
  2. Published

    PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Trebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F. E., Jansen, C., Jimenez, C., Mookerjee, R., Gustot, T., Albillos, A., Bañares, R., Jarcuska, P., Steib, C., Reiberger, T., Acevedo, J., Gatti, P., Shawcross, D. L. & 31 others, Zeuzem, S., Zipprich, A., Piano, S., Berg, T., Bruns, T., Danielsen, K. V., Coenraad, M., Merli, M., Stauber, R., Zoller, H., Ramos, J. P., Solé, C., Soriano, G., de Gottardi, A., Gronbaek, H., Saliba, F., Trautwein, C., Kani, H. T., Francque, S., Ryder, S., Nahon, P., Romero-Gomez, M., Van Vlierberghe, H., Francoz, C., Manns, M., Garcia-Lopez, E., Tufoni, M., Amoros, A., Bendtsen, Flemming, Gluud, Lise Lotte & PREDICT STUDY group of the EASL-CLIF CONSORTIUM, P. S. G. O. T. E. C., 2021, In: Journal of Hepatology. 74, 5, p. 1097-1108

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson's Disease: A Dynamic PC-MRI Study

    Siebner, T. H., Fugl Madelung, C., Bendtsen, Flemming, Løkkegaard, Annemette, Hove, Jens Dahlgaard & Siebner, Hartwig Roman, 2021, In: Journal of Parkinson's Disease. 11, 2, p. 545-557 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation

    Thiele, M., Johansen, S., Gudmann, N. S., Madsen, B., Kjærgaard, M., Nielsen, M. J., Leeming, D. J., Jacobsen, S., Bendtsen, Flemming, Møller, Søren, Detlefsen, S., Karsdal, M., Krag, A. & the GALAXY Consortium, T. G. C., 2021, In: Alimentary Pharmacology and Therapeutics. 54, 8, p. 1070-1080

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study

    Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

    Attauabi, M., Zhao, M., Bendtsen, Flemming & Burisch, J., 2021, In: Inflammatory Bowel Diseases. 27, 6, p. 927–939

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease

    Attauabi, M., Zhao, M., Bendtsen, Flemming & Burisch, J., 2021, In: Therapeutic Advances in Gastroenterology. 14, p. 1-5

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis

    Kimer, N., Gluud, Lise Lotte, Pedersen, J. S., Tavenier, J., Møller, Søren & Bendtsen, Flemming, 2021, In: Translational Gastroenterology and Hepatology. 6, 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis

    Danielsen, K. V., Hove, Jens Dahlgaard, Nabilou, P., Yin, M., Chen, J., Zhao, M., Kallemose, T., Teisner, A. S., Siebner, Hartwig Roman, Ehman, R. L., Møller, Søren & Bendtsen, Flemming, 2021, In: Liver International. 41, 9, p. 2149-2158 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

    Attauabi, M., Höglund, C., Fassov, J., Pedersen, K. B., Hansen, H. B., Wildt, S., Jensen, M. D., Neumann, A., Lind, C., Jacobsen, H. A., Popa, A. M., Kjeldsen, J., Pedersen, N., Molazahi, A., Haderslev, K., Aalykke, C., Knudsen, T., Cebula, W., Munkholm, P., Bendtsen, F. & 2 others, Seidelin, Jakob Benedict & Burisch, J., 2021, In: Scandinavian Journal of Gastroenterology. 56, 9, p. 1040-1048

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2020
  12. Published

    Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Wiese, S., Voiosu, A., Hove, Jens Dahlgaard, Danielsen, K. V., Voiosu, T., Grønbaek, H., Møller, H. J., Genovese, F., Reese-Petersen, A. L., Mookerjee, R. P., Clemmesen, J. O., Gøtze, J. P., Andersen, Ove, Møller, Søren & Bendtsen, Flemming, Jul 2020, In: Alimentary Pharmacology and Therapeutics. 52, 2, p. 340-350 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...33 Next

ID: 13212